cover
Article Per Year (5 Year)
All
Home Page
OAI Link
Editorial Team
Contact
Reviewer
Google Scholar
Contact Name
-
Contact Email
mrj@ub.ac.id
Phone
+6285234550155
Journal Mail Official
mrj@ub.ac.id
Editorial Address
Malang Respiratory Journal Department of Pulmonology Respiratory Medicine Universitas Brawijaya mrj@ub.ac.id
Location
Kota malang,
Jawa timur
INDONESIA
Malang Respiratory Journal
Published by Universitas Brawijaya
ISSN : 27457842     EISSN : 27226492     DOI : https://doi.org/10.21776/ub.mrj
Core Subject : Health, Science, Education,
Biochemistry, Genetics & Molecular Biology Education Health Professions Immunology & microbiology Medicine & Pharmacology Public Health Other
Malang Respiratory Journal is the official open-access journal of Department of Pulmonology Respiratory Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia. It publishes articles two times per year. It is a peer reviewed publication of Indonesian Pulmonology and Respiratory journals and accepting articles for publication from around the world. MRJ only publishes articles in the English version. The objective of this journal is publishing the selected clinical and basic research relevant to Pulmonology and Respiratory. It covers the following topics such as infection, thoracic oncology, asthma and COPD, interventional pulmonology and respiratory emergency, occupational and environmental pulmonology, and clinical immunology. It is an international journal dedicated to provide new information that could give a new insight for alternative solutions, diagnosis, therapy and prevention for researchers and practitioners in Pulmonology Respiratory Medicine.
Arjuna Subject : Kedokteran - Kedokteran Paru dan Pernafasan
Articles 5 Documents
 1 
Search results for , issue "Vol. 5 No. 1 (2023): Volume 5 No 1, March 2023" : 5 Documents clear
A Case Report : Bronchopleural Fistula Dextra with Pyopneumothorax Dextra as Complication of Lung Tuberculosis Kevin Wahyudy Prasetyo; Jane R Sugiri Jani; Rachma Erawati Dini; Kurnia Wardhana
Malang Respiratory Journal Vol. 5 No. 1 (2023): Volume 5 No 1, March 2023
Publisher : Universitaas Brawijaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21776/ub.mrj.2023.005.01.2

Abstract

Background: Bronchopleural fistula is a rare case that might be caused by trauma, post lung resection surgery, and non traumatic cause such as lung Tuberculosis infection. Bronchopleural fistula is a serious complication of lung TB which almostly related to pleural cavity infection. This fistula condition may be accompanied with empyema that can cause secondary spontaneous pneumothorax. The diagnosis of fistula is established by combination of clinical symptoms regarding lung TB infection, radiology, laboratory, microbiology, dan histopathologi examinations. Management of bronchopleural fistula includes chest tube insertion to treat pyopneumothorax problem, fistula repair surgery, and underlying disease and its comorbid. Case: We report one case located at Dr. Saiful Anwar hospital, a 36 year old woman with symptoms of dyspneu and chronic cough with purulent sputum. Based on the clinical data, laboratory results, radiological imaging, sputum examination, and plerual fluid analysis and cytology, diagnosis of bronchopleural fistula together with pyopneumothorax as complication of lung TB was made. Management of this patient comprises of chest tube insertion, fistula repair surgery, antibiotic, and OAT. Conclusion: Bronchopleural fistula is a rare case found. Proper surgical management and treating underlying disease such as lung TB might improve clinical outcome and reduce mortality rate. Keywords: Bronchopleural fistula, Pyopneumothorax, Lung TB
The Case Report : Challenges in the Management of Pneumothorax for COVID-19 Patient Adinda Pramitra Permatasari; Sastia Rakhma; Ngakan Putu Parsama Putra
Malang Respiratory Journal Vol. 5 No. 1 (2023): Volume 5 No 1, March 2023
Publisher : Universitaas Brawijaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21776/ub.mrj.2023.005.01.1

Abstract

INTRODUCTION : Pneumothorax has been reported in minority of COVID-19 cases. Spontaneus Pneumothorax is an uncommon complication of COVID-19. The incidence and risk factors are still unknown. Here we will review where there are challenges with case of Pneumothorax in COVID-19 patients. CASE ILLUSTRATION : We report one case at Dr. Saiful Anwar hospital, a 42 years old man was diagnosed with Spontaneous Pneumothorax and tested positive for COVID-19 via nasopharyngeal swab. Management in this case requires consideration from emergency treatment, risk of virus transmission and the aerolization of the procedure. Invasive procedure such as insertion chest tube and pharmacologic therapy be the treatment in this case. After 2 weeks of treatment, there was improvement on clinical and radiological imaging. DISCUSSION : Various strategies to reduce the risk of exposure to COVID-19 infection on Spontaneus Pneumothorax. This literature discusses about the risk factor that lead to Pneumothorax with COVID-19 and the management of Pneumothorax cases in COVID-19 patients. CONCLUSION: Spontaneous Pneumothorax is a rare complication of COVID-19. Management in this case requires consideration from emergency treatment, risk of virus transmission and the aerolization of the procedure. Key words : Pneumothorax; COVID-19; Chest Tube
Successful Embolization in Recurrent Hemoptysis Caused by Pulmonary Aspergilloma: A Case Report: Successful Embolization in Recurrent Hemoptysis Caused by Pulmonary Aspergilloma Muli Yaman; Jane Sugiri; Ngakan Putra; Dewi Santosaningsih; Achmad Aslam
Malang Respiratory Journal Vol. 5 No. 1 (2023): Volume 5 No 1, March 2023
Publisher : Universitaas Brawijaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21776/ub.mrj.2023.005.01.4

Abstract

Background: Aspergilloma is a fungal infection that can cause recurrent hemoptysis. One of the treatment modalities is embolization, which has a success rate of 85% to 100%, although the recurrence rate may reach 10% to 33%. Case Illustration: A 29-year-old female came to the emergency ward with recurrent hemoptysis. She had a history of tuberculosis with completed treatment 7 years ago. Chest radiography showed left lung tuberculosis with emphysematous lung. Chest CT with contrast revealed an air-crescent sign, and culture from bronchoalveolar lavage (BAL) showed Aspergillus spp. Then, she was diagnosed with pulmonary aspergilloma. Embolization was performed in the left internal mammary artery, and the blushing was decreased by 80%. However, the hemoptysis was still recurrent; a second embolization was performed in the left supreme intercostal artery, costocervical trunk artery, and bronchial artery, resulting in no blushing. The patient had no further episodes of hemoptysis, and her antifungal therapy was changed from fluconazole to voriconazole. Discussion: Recurrent hemoptysis can be caused by pulmonary aspergilloma. Embolization is usually done to reduce bleeding before surgery. The patient had performed embolization 2 times with no further episodes of hemoptysis. Surgical resection as a definitive treatment was recommended in this case, but the patient refused. Therefore, the patient’s management was optimized using voriconazole and embolization for the hemoptysis. Conclusion: Management of recurrent hemoptysis in patients with aspergilloma may include embolization and antifungal treatment which give improved clinical outcomes. Keywords: recurrent hemoptysis, embolization, aspergilloma, tuberculosis
Severe Abdominal Pain Due To Gastrointestinal Obstruction in Patient With Lung Adenosquamous Metastases in Colon Zata Dini; Suryanti Pratiwi; Ungky Setyawan; Aries Budianto; Hendy Yudhanto; Dini Erawati
Malang Respiratory Journal Vol. 5 No. 1 (2023): Volume 5 No 1, March 2023
Publisher : Universitaas Brawijaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21776/ub.mrj.2023.005.01.5

Abstract

Background: Lung cancer is the most common cause of cancer-related death globally. Moreover, metastatic cancer from the lungs frequently occurs and is commonly identified at the first diagnosis. The primary cancer must be identified in order to establish the most effective treatment. However, colonic metastases are rare with incidence of 0,1%. Aim: This report describes an unusual case of colonic metastases from lung adenocarcinoma. Methods: Patient (58-year-old male) was examined with Fiber Optic Bronchoscopy and core biopsy in the lungs, and the results were suspicious for squamous cells. The patient had severe abdominal pain and bloating for 1 week and had signs of gastrointestinal obstruction in his second visit. The result of urgent laparotomy was adenosquamous and the result of immunohistochemical examination was negative P40 and positive Napsin A in both lungs and colon. Results: The lung biopsy result indicated squamous cell and the ceccum showed adenosquamous. The immunohistochemical examination using P40 and Napsin A of both lung and ceccum specimens indicated that the lung was the primary source of metastases to the colon. Conclusion: The patient suffered from a squamous cell lung tumor and reported severe abdominal pain due to metastases to the colon with adenosquamous results.
Pulmonary Tuberculosis Patient with destroyed lung: Case Report David Saragih; Anak Upeksha
Malang Respiratory Journal Vol. 5 No. 1 (2023): Volume 5 No 1, March 2023
Publisher : Universitaas Brawijaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21776/ub.mrj.2023.005.01.3

Abstract

Tuberculosis is still a concern of WHO because there is an increase in TB cases, especially in Southeast Asia, one of which is Indonesia, which is the second in the world that has not shown a decrease in cases. Where people who have comorbid diseases are more susceptible to tuberculosis. Destroyed lung is a lung damage caused by tuberculosis.

Page 1 of 1 | Total Record : 5

 1 

Filter by Year

2023 2023


Reset
Filter By Issues
All Issue Vol. 5 No. 1 (2023): Volume 5 No 1, March 2023 Vol. 5 No. 2 (2023): September Edition Vol. 4 No. 2 (2022): September 2022 Vol 3, No 2 (2021): Vol. 3 No. 2 Vol 3, No 1 (2021): Vol. 3 No. 1 Vol 2, No 02 (2020) Vol 2, No 01 (2020): Shape the Curves Vol 1, No 1 (2019): The Many Faces of Respiratory Disease